Foreign Corrupt Practices Act: Investigations Dataset

Investigation Name: Investigation into Novartis' Activities with Health Care Providers in Greece

Trend: None

Type of investigation: Internal, SEC, DOJ

Other Agencies Investigating/Assisting with SEC/DOJ Investigation:

Greek Body of Prosecution of Financial Crime
Greek Coordinating Body for Inspection and Control

Whistleblower: Unknown

Summary

Novartis AG was a global provider of pharmaceutical and healthcare products incorporated and headquartered in Switzerland. Novartis' securities were registered with the SEC and traded on the New York Stock Exchange.

In a 6-K filed on January 25, 2017, Novartis disclosed that it had begun investigating allegations of "potentially inappropriate economic benefits" to health care providers, government officials, and others in Greece. Information was being provided to Greek authorities, and the company was also responding to document requests from the DOJ and SEC.

On January 24, 2018, Novartis disclosed that the DOJ and/or the SEC had also subpoenaed the company for information connected to the Greek investigation.

Novartis said it cooperated in the US agencies' investigations.

On June 25, 2020, the DOJ and SEC filed enforcement actions against Novartis and two of its subsidiaries.

Protected Content

Please Log In or Sign Up for a free account to access restricted features of the Clearinghouse website, including the Advanced Search form and the full case pages.

When you sign up, you will have the option to save your search queries performed on the Advanced Search form.

| Investigations Dataset

Investigations Dataset

Information & Summary

Investigation into Novartis' Activities with Health Care Providers in Greece

Information & Summary

Protected Content